Palantir's Bold Biosecurity Opportunity Could Boost Returns
Palantir sits at a crossroads of defense data and biotech action. This article explores why palantir's bold biosecuri...
This opening paragraph covers which world indices qualify as total return indices and how dividends boost overall performance.
21,675 articlesPalantir sits at a crossroads of defense data and biotech action. This article explores why palantir's bold biosecuri...
A trusted economics forecaster nailed a 4.2% inflation reading months ahead of the Federal Reserve. Now, they offer a...
Markets confront a paradox: AI’s potential is immense, but real-world adoption is uneven. Household budgets and inves...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
When a planning nonprofit secretary found a discrepancy in the group’s bank records, it set off a federal fraud inves...
Belgium has cut tariffs on a targeted set of goods, a move that aims to ease costs for manufacturers and shoppers ali...
SK Hynix plans a $29 billion U.S. listing to capitalize on AI memory chip demand, highlighting a push to broaden inve...
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Real estate professionals push back at NAR's trademark enforcement drive during midyear meetings, arguing it diverts ...
If you missed Nvidia's historic run, you're not out of luck. This article outlines two solid AI-focused winners at di...
A Dutch consumer group filed a $457 million lawsuit against Sony over its plan to drop PS5 discs by 2028, arguing the...
A former SWIFT official punctured rumors that Ripple XRP could be integrated into SWIFT's payments network. At the sa...